 |
|
Researcher Profile - Assen Jablensky |
|
|
|
| First Name: | Assen | | Last Name: | Jablensky | | Title: | Professor | | Advanced Degrees: | MD, DMSc, FRCPsych, FRANZCP | | Affiliation: | The University of Western Australia | | Department: | School of Psychiatry and Clinical Neurosciences | | Street Address 1: | MRF Building Level 3 | | Street Address 2: | 50 Myrray Street | | City: | Perth | | State/Province: | Western Australia | | Zip/Postal Code: | 6000 | Country/Territory: | Australia | | Phone: | +61-8-9224-0290 | | Fax: | +61-8-9224 o285 | | Email Address: |  |
Disclosure:
(view policy) |
Member reports no financial or other potential conflicts of interest. [Last Modified: 20 October 2005]
|
|
|
View all comments by Assen Jablensky
|
Neurodevelopmental disorders (e.g., 22q11 deletion syndromes), Bipolar disorder , Schizophrenia, Autism spectrum disorders (pervasive developmental disorders)
|
Animal models, Neurodevelopment, Neurotransmission, Phenomenology/diagnosis, Epidemiology, Genetics, Brain imaging, Neuropathology, Pharamacology, Electrophysiology
|
Medical hospital, Research institute, University
|
Having completed his medical degree and training as a psychiatrist in Bulgaria and the UK, Prof A. Jablensky has worked as a clinician and researcher in Switzerland (WHO, Geneva), the US (Stanford University) and Bulgaria, where he was Director of the National Program of Brain and Behaviour Research (1987-1992). The main focus of his research is on psychiatric epidemiology, genetics, classification of mental disorders, and psychotic disorders. From 1974 to 1987, he held a senior position with the World Health Organization in Geneva, being in charge of cross-cultural epidemiological research into schizophrenia and depression. This included the influential WHO Ten-Country Study on Schizophrenia (Jablensky et al: Schizophrenia: manifestations, incidence and course in different cultures. Psychological Medicine 1992, Monogr Suppl 20:1-97), remaining as one of the most widely quoted papers in the psychiatric literature, with over 450 citations by 2004). During 1982-1987 he chaired the WHO Task Force which developed the ICD-10 diagnostic criteria for mental disorders. Since moving to Australia in 1993, Prof Jablensky has been Chief Investigator of the Study on Low-Prevalence (Psychotic) Disorders, as part of the Australian National Survey of Mental Health and Wellbeing (1997-1998) and Director of the Centre for Clinical Research in Neuropsychiatry (University of Western Australia), in addition to being the Chief Investigator on a number of NHMRC and overseas (US) research grants. In 1999-2001 he was Co-Chairman, Committee on Nervous System Disorders in Developing Countries, Institute of Medicine, US National Academy of Sciences, Washington DC; and in 2003, he was appointed to the Committee on Brain and Mind Disorders of the Australian Prime Minister’s Science, Engineering and Innovation Council (PMSEIC). He has served on numerous research-related committees, including the NHMRC panel on mental health, of which he was Deputy Chair, and the UWA Vice Chancellor’s Research Leaders Forum. He is Corresponding Editor of the British Journal of Psychiatry and member of the editorial boards of Schizophrenia Research, International Review of Psychiatry, Australian and New Zealand Journal of Psychiatry, and several other journals. Prof Jablensky has over 250 publications, of which > 90 are articles in peer-reviewed research journals and > 100 are book chapters and books. He has been awarded the Strömgren Prize and medal for psychiatric epidemiology; the ASPR Founders Medal, the Organon Research Prize, and several other awards. Apart from research, Prof. Jablensky is a practicing clinician and teacher. |
Hallmayer JF, Kalaydjieva L, Badcock J, Dragovic M, Howell S, Michie PT,Rock D, Vile D, Williams R, Corder EH, Hollingsworth K, Jablensky A.
Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am J Hum Genet. 2005 Sep;77(3):468-76. Epub 2005 Jul 12.
PMID: 16080121
Castle DJ, Jablensky A, McGrath JJ, Carr V, Morgan V, Waterreus A, Valuri G,
Stain H, McGuffin P, Farmer A. The diagnostic interview for psychoses (DIP): development, reliability and
applications. Psychol Med. 2005 Sep 29;:1-12 PMID: 16194284
Jablensky A. Categories, dimensions and prototypes: critical issues for psychiatric
classification. Psychopathology. 2005 Jul-Aug;38(4):201-5. PMID: 16145275
Dragovic M, Hammond G, Badcock JC, Jablensky A. Laterality phenotypes in patients with schizophrenia, their siblings and
controls: associations with clinical and cognitive variables.Br J Psychiatry. 2005 Sep;187:221-8.
PMID: 16135858
Dragovic M, Hammond G, Jablensky A. Schizotypy and mixed-handedness revisited.
Psychiatry Res. 2005 Sep 15;136(2-3):143-52. PMID: 16112739
Morgan VA, Mitchell PB, Jablensky AV. The epidemiology of bipolar disorder: sociodemographic, disability and service
utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders.
Bipolar Disord. 2005 Aug;7(4):326-37. PMID: 16026485
Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women
women with schizophrenia and major affective disorders.Am J Psychiatry. 2005 Jan;162(1):79-91.PMID: 15625205
Jablensky A. Resolving schizophrenia's CATCH22.Nat Genet. 2004 Jul;36(7):674-5. PMID: 15226748
Hallmayer JF, Jablensky A, Michie P, Woodbury M, Salmon B, Combrinck J,Wichmann H, Rock D, D'Ercole M, Howell S, Dragovic M, Kent A.
Linkage analysis of candidate regions using a composite neurocognitive phenotype correlated with schizophrenia.
Mol Psychiatry. 2003 May;8(5):511-23.
PMID: 12808431
Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses.
Am J Psychiatry. 2003 Jan;160(1):4-12. PMID: 12505793 |
Catani M, ffytche DH: The rises and falls of dysconnection syndromes. Brain (2005) 128:2224-2239
McQueen MB et al: Combined analysis from eleven linkage studies of bipolar disorder. Am J Hum Genet (2005) 77:582-595
Rhee SH et al: Testing hypotheses regarding the causes of comorbidity. J Abnorm Psychol (2005) 114:346-362 |
Large schizophrenia case-control sample whole-genome association screening
Prospective, hypothesis-based studies on cognitive deficits in schizophrenia |
|
|
|
|
|
